| abstract |
The present invention relates to a humanized antiboby or fragment thereof that binds to human CD19. More specifically, the present invention relates to heavy chain CDR1 consisting of the amino acid sequence of SEQ ID NO: 27, and / or heavy chain CDR2 consisting of the amino acid sequence of SEQ ID NO: 28, and / or amino acid of SEQ ID NO: 29 Heavy chain CDR3 consisting of the sequences; And / or light chain CDR1 consisting of the amino acid sequence of SEQ ID NO: 30, and / or light chain CDR2 consisting of the amino acid sequence of SEQ ID NO: 31, and / or light chain consisting of the amino acid sequence of SEQ ID NO: 32 A humanized antibody or fragment thereof that binds to human CD19 consisting of CDR3. |